Low plasma taurine and later neurodevelopment

B A Wharton1, R Morley, E B Isaacs

  • 1Childhood Nutrition Research Centre, Institute of Child Health, London WC1 1EH, UK. bwharton@ich.ucl.ac.uk

Insights

Dietary taurine intake is crucial for infant neurodevelopment, potentially explaining breast milk benefits. Low taurine levels in newborns were linked to poorer cognitive scores later in childhood.

Area of Science:

  • Nutritional Neuroscience
  • Developmental Pediatrics

Background:

  • Breast milk provides taurine, an amino acid vital for infant development.
  • Preterm formulas aim to mimic breast milk's nutritional profile.
  • The role of taurine in neurodevelopment requires further elucidation.

Purpose of the Study:

  • To investigate the association between neonatal taurine levels and long-term neurodevelopmental outcomes.
  • To assess the potential impact of dietary taurine on cognitive development in infants.

Main Methods:

  • Plasma taurine levels were measured in neonates.
  • Neurodevelopmental assessments, including the Bayley Mental Development Index and WISC-R arithmetic subtest, were conducted at 18 months and 7 years, respectively.
  • Correlation analysis was used to determine the relationship between taurine levels and cognitive scores.

Main Results:

  • Lower plasma taurine concentrations in neonates were significantly associated with lower Bayley Mental Development Index scores at 18 months.
  • A similar association was observed between low neonatal taurine and reduced performance on the WISC-R arithmetic subtest at 7 years.
  • These findings suggest a critical role for taurine in early brain development.

Conclusions:

  • Neonatal taurine status is a potential predictor of cognitive development.
  • Current infant formulas do not have mandatory taurine fortification, which may warrant reconsideration.
  • Ensuring adequate taurine intake during infancy is important for optimal neurodevelopment.

Related Concept Videos

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...